Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Frontline Plc Ordinary Shares (FRO) vs GSK plc (GSK) Price & Performance

Frontline Plc Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Frontline Plc Ordinary Shares vs GSK plc — how do they compare? Frontline Plc Ordinary Shares trades at $55.95 (market cap $12.52B), while GSK plc trades at $46.62 (market cap $91.88B). The key difference: GSK plc is far larger — about 7.3× Frontline Plc Ordinary Shares's market cap, and Frontline Plc Ordinary Shares pays the higher dividend (9.56%). Which is the better fit depends on your goals — on Pluang, investors hold Frontline Plc Ordinary Shares for 0 Days and GSK plc for 93 Days on average.

FROGSK
Market Cap
$12.52B$91.88B
Volume
6,375,5097,730,529
Sector
IndustrialsHealth
52-Week High
$56.26$61.18
52-Week Low
$20.58$43.24
Typical Hold Time
0 Days93 Days
Enterprise Value
$14.64B$111.88B
Dividend Yield
9.56%3.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Frontline Plc Ordinary Shares

No Aura AI signal available yet.

GSK plc

GSK trades at $46.45, down 1.21% with bearish technical signals. The company shows strong fundamentals with revenue growth to $32.67B in 2025 and consistent earnings beats. Valuation metrics appear reasonable with P/E of 14.89 and EV/EBITDA of 8.75. Recent developments include strategic oncology partnerships and a $750M cancer therapy acquisition, positioning for long-term growth despite near-term technical weakness.

GSK presents a mixed outlook with strong profitability and pipeline expansion offset by technical bearishness and HIV patent concerns. The company's 29.73% ROE and recent earnings outperformance support investment appeal, while the bearish moving average signal and competitive pressures warrant caution. Analyst consensus leans hold with 55% neutral rating, suggesting balanced risk-reward for long-term investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FRO
19% Buy81% Sell
Avg holding period · 0 Days
GSK
100% Buy0% Sell
Avg holding period · 93 Days

Top news

Latest headlines on both assets

About Frontline Plc Ordinary Shares

Frontline operates a fleet of oil tankers that transport crude oil by sea. Its vessels serve global energy trading routes.

Read more on FRO →

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK →